Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2023-03-26 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
北京大成（合肥）律师事务所关于安徽峆一药业股份有限公司向不特定合格投资者公开发行股票并在北京证券交易所上市超额配售选择权实施情况的法律意见
Capital/Financing Update Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the implementation of an over-allotment option (also known as a greenshoe option) related to a public stock issuance and listing on the Beijing Stock Exchange by Anhui Fuyi Pharmaceutical Co., Ltd. It details the legal compliance, internal approvals, and specifics of the over-allotment exercise, including share allotment, strategic investor agreements, and regulatory adherence. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to capital issuance and stock offering activities. This fits best under the category of Capital/Financing Update (CAP), as it provides detailed information on the company's fundraising and capital structure changes through the exercise of the over-allotment option.
2023-03-26 Chinese
国元证券股份有限公司关于安徽峆一药业股份有限公司向不特定合格投资者公开发行股票并在北京证券交易所上市超额配售选择权实施情况的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from Guoyuan Securities regarding the implementation of an over-allotment option (also known as a greenshoe option) related to a public stock issuance by Anhui Peiyi Pharmaceutical Co., Ltd. It includes specifics about the number of shares issued, the exercise of the over-allotment option, the funds raised, shareholding changes, and compliance with regulatory requirements. The document is not a brief announcement but a substantive verification opinion on the over-allotment option exercise, which is a capital market activity related to financing. It does not contain quarterly or annual financial statements, nor is it a general regulatory filing or a simple announcement of a report. The content fits best under Capital/Financing Update (CAP) as it details the issuance and exercise of shares and related capital changes.
2023-03-26 Chinese
2022年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2022 Annual Performance Express Announcement" and contains preliminary financial data for the year 2022, including revenue, net profit, earnings per share, and asset information. It explicitly states that the data is preliminary, unaudited, and subject to the final audited annual report. The document is relatively short (1602 characters) and serves as a quick earnings update rather than a full annual report. It does not contain full financial statements or detailed analysis but rather summarized key financial metrics and a caution about the preliminary nature of the data. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2022
2023-02-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.